TABLE 5.
Analyte | Correlated with | r a | P value |
---|---|---|---|
cPLI0 | IL‐61 | .75 | 0 |
CRP0 | .52 | .005 | |
cPLI1 | IL‐60 | .55 | .003 |
IL‐61 | .68 | 0 | |
IL‐6max | .57 | .001 | |
Ionized calcium | −.62 | .009 | |
CRP0 | IL‐61 | .58 | .001 |
cholesterol | .68 | 0 | |
TG | .52 | .023 | |
CRP1 | IL‐61 | .65 | 0 |
IL‐6max | .51 | .006 | |
Ionized calcium | −.67 | .003 | |
CRPmax | IL‐61 | .58 | .001 |
IL‐6max | .62 | 0 | |
Ionized calcium | −.58 | .009 | |
Cholesterol | .58 | .001 | |
IL‐20 | IL‐60 | .65 | 0 |
IL‐6max | .56 | .001 | |
IL‐80 | .92 | 0 | |
IL‐81 | .60 | .001 | |
IL‐8max | .74 | 0 | |
TNFα1 | .53 | .004 | |
IL‐21 | IL‐81 | .89 | .000 |
IL‐8max | .84 | .000 | |
TNFα0 | .504 | .007 | |
TNFα1 | .80 | 0 | |
TNFαmax | .84 | 0 | |
Hemoglobin | −.52 | .007 | |
Hematocrit | −.53 | .005 | |
IL‐2max | IL‐61 | .61 | .001 |
IL‐80 | .67 | 0 | |
IL‐81 | .89 | 0 | |
IL‐8max | .82 | 0 | |
TNFα1 | .839 | 0 | |
Hematocrit | −.53 | .003 | |
IL‐61 | Ionized calcium | −.73 | .001 |
Amylase | .62 | .001 | |
IL‐80 | TNFα1 | .60 | .001 |
IL‐81 | TNFα0 | .59 | .001 |
TNFα1 | .86 | .000 | |
TNFαmax | .93 | 0 | |
α1PI0 | Duration of clinical signs | −.50 | .002 |
α2antiplasmin0 | Duration of clinical signs | −.52 | .007 |
Notes: Subscripts 0, 1 max and min refer to concentrations on day 0 (presentation), day 1 (1 day post‐presentation), maximal and minimal concentrations during days 0 and 1, respectively.
Abbreviations: α1PI, α1‐proteinase inhibitor concentration; clinical signs duration, lag of time from onset of clinical signs to presentation to the hospital; cPLI, canine pancreatic‐like immunoreactivity; CRP, C‐reactive protein; IL, interleukin; TNFα, tumor necrosis factor α.
Spearman's correlation tests were done when ≥1 of the tested variables had non‐normal distribution, whereas Pearson's correlation tests were done when both tested variables were distributed normally.